Lifeway Foods upgraded by Noble Capital Markets with a new price target
$LWAY
Packaged Foods
Consumer Staples
Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $13.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/24/2024 | Outperform → Market Perform | Noble Capital Markets | |
| 5/30/2024 | $20.00 | Market Perform → Outperform | Noble Capital Markets |
| 4/5/2024 | $25.00 | Buy | Lake Street |
| 3/27/2024 | Outperform → Market Perform | Noble Capital Markets | |
| 2/26/2024 | $14.00 | Market Perform → Outperform | Noble Capital Markets |
| 11/27/2023 | Outperform → Market Perform | Noble Capital Markets | |
| 11/14/2023 | $13.00 | Market Perform → Outperform | Noble Capital Markets |
| 9/25/2023 | Outperform → Market Perform | Noble Capital Markets |
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
4 - Lifeway Foods, Inc. (0000814586) (Issuer)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)
Net sales of $46.1 million; up 3.3% year-over-year Consumer demand for probiotic Lifeway products drives 22nd consecutive quarter of year-over-year sales growth MORTON GROVE, Ill., May 13, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the first quarter ended March 31, 2025. "We're thrilled to begin 2025 with continued topline momentum, delivering our 22nd consecutive quarter of year-over-year net sales growth," comme
CHICAGO, May 2, 2025 /PRNewswire/ -- Edward Smolyansky, who together with Ludmila Smolyansky, beneficially own approximately 27% of outstanding shares of Lifeway Foods common stock, today issued the following statement in response to Lifeway's amended 2024 Annual Report and its latest disclosures on executive and director compensation. Apparent Delay of 2025 Annual Meeting of Shareholders On March 13, Edward Smolyansky submitted a full slate of Board nominees for Lifeway's 2025 Annual Meeting. To date, Lifeway has yet to file a preliminary or definitive proxy statement setting forth its own slate. "The filing of the amended 2024 Annual Report, and other steps taken recently by the Company,
Company to Report First Quarter 2025 Results on May 13, 2025 MORTON GROVE, Ill., April 29, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced a milestone achievement of surpassing $5 million in gross sales for the week ending April 27th, 2025, representing a 35% increase from the prior year. The Company expects to report financial results for the first quarter ended March 31, 2025 on May 13, 2025 before market hours. A pre-recorded con
Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform
Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00
Lake Street initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $25.00
10-Q - Lifeway Foods, Inc. (0000814586) (Filer)
8-K - Lifeway Foods, Inc. (0000814586) (Filer)
10-K/A - Lifeway Foods, Inc. (0000814586) (Filer)
Net sales of $46.1 million; up 3.3% year-over-year Consumer demand for probiotic Lifeway products drives 22nd consecutive quarter of year-over-year sales growth MORTON GROVE, Ill., May 13, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the first quarter ended March 31, 2025. "We're thrilled to begin 2025 with continued topline momentum, delivering our 22nd consecutive quarter of year-over-year net sales growth," comme
Company to Report First Quarter 2025 Results on May 13, 2025 MORTON GROVE, Ill., April 29, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced a milestone achievement of surpassing $5 million in gross sales for the week ending April 27th, 2025, representing a 35% increase from the prior year. The Company expects to report financial results for the first quarter ended March 31, 2025 on May 13, 2025 before market hours. A pre-recorded con
Company achieves 2024 net sales of $186.8 million; up 17% year-over-year 21st consecutive quarter of year-over-year growth Growing consumer interest in probiotic foods with bioavailable nutrients continues to drive strong demand for Lifeway products MORTON GROVE, Ill., March 14, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the fourth quarter and full year ended December 31, 2024. "I am pleased to report another reco